icrf 193 has been researched along with bufalin in 1 studies
| Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (bufalin) | Trials (bufalin) | Recent Studies (post-2010) (bufalin) |
|---|---|---|---|---|---|
| 155 | 0 | 30 | 333 | 0 | 205 |
| Protein | Taxonomy | icrf 193 (IC50) | bufalin (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.45 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 2.76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortés, F; Domínguez, I; Mateos, S; Pastor, N | 1 |
1 other study(ies) available for icrf 193 and bufalin
| Article | Year |
|---|---|
Testing the SCE mechanism with non-poisoning topoisomerase II inhibitors.
Topics: Animals; Bufanolides; CHO Cells; Chromosome Aberrations; Cricetinae; Diketopiperazines; DNA Repair; Enzyme Inhibitors; Models, Genetic; Mutation; Piperazines; Recombination, Genetic; Sister Chromatid Exchange; Topoisomerase II Inhibitors | 2001 |